DK0502313T3 - Fremgangsmåde til sikring af tilstrækkeligt intracellulært glutathion i væv - Google Patents

Fremgangsmåde til sikring af tilstrækkeligt intracellulært glutathion i væv

Info

Publication number
DK0502313T3
DK0502313T3 DK92101515.2T DK92101515T DK0502313T3 DK 0502313 T3 DK0502313 T3 DK 0502313T3 DK 92101515 T DK92101515 T DK 92101515T DK 0502313 T3 DK0502313 T3 DK 0502313T3
Authority
DK
Denmark
Prior art keywords
tissues
intracellular glutathione
ensuring adequate
glutathione
adequate intracellular
Prior art date
Application number
DK92101515.2T
Other languages
English (en)
Inventor
David A Mark
W Bruce Rowe
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of DK0502313T3 publication Critical patent/DK0502313T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK92101515.2T 1991-02-04 1992-01-30 Fremgangsmåde til sikring af tilstrækkeligt intracellulært glutathion i væv DK0502313T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65022291A 1991-02-04 1991-02-04

Publications (1)

Publication Number Publication Date
DK0502313T3 true DK0502313T3 (da) 1998-02-02

Family

ID=24608000

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92101515.2T DK0502313T3 (da) 1991-02-04 1992-01-30 Fremgangsmåde til sikring af tilstrækkeligt intracellulært glutathion i væv

Country Status (9)

Country Link
EP (1) EP0502313B1 (da)
JP (1) JPH04327537A (da)
AT (1) ATE155344T1 (da)
AU (1) AU652988B2 (da)
CA (1) CA2060560C (da)
DE (1) DE69220821T2 (da)
DK (1) DK0502313T3 (da)
ES (1) ES2106096T3 (da)
GR (1) GR3024638T3 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214062A (en) * 1992-04-08 1993-05-25 Clintec Nutrition Co. Method and composition for treating immune disorders, inflammation and chronic infections
AU5040493A (en) * 1992-11-30 1994-06-09 Transcend Therapeutics, Inc Method for treating systemic inflammatory response syndrome
AU6060694A (en) * 1993-05-10 1994-11-17 Transcend Therapeutics, Inc Method for treating acquired immune deficiency syndrome
US5578576A (en) * 1994-09-02 1996-11-26 Dalhousie University Method and composition for treating intestinal wounds or ulcers
US5821217A (en) * 1995-10-27 1998-10-13 Beth Israel Deaconess Medical Center, Inc. Enteral formulation: low in fat and containing protein hydrolysates
US6251857B1 (en) 1995-12-14 2001-06-26 Novelos Therapeutics, Inc. Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
RU2089179C1 (ru) * 1995-12-14 1997-09-10 Закрытое акционерное общество "ВАМ" Стимулятор эндогенной продукции цитокинов и гепопоэтических факторов и способ его использования
RU2144374C1 (ru) 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
US20070142267A1 (en) 1998-11-23 2007-06-21 Novelos Therapeutics, Inc. Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
BRPI0414505A (pt) * 2003-09-19 2006-11-07 Nutricia Nv uso de carboidratos solúveis em água digerìveis e de um ou mais promotores da glutationa, e, composição
JP2006219458A (ja) * 2005-02-14 2006-08-24 Meiji Milk Prod Co Ltd 虚血性腸疾患抑制剤
JP5784869B2 (ja) * 2008-04-28 2015-09-24 太陽化学株式会社 抗炎症剤
CN101880702B (zh) * 2009-05-07 2012-12-12 成都自豪药业有限公司 一种采用产朊假丝酵母发酵生产谷胱甘肽的方法
WO2017016631A1 (en) * 2015-07-30 2017-02-02 Merck Patent Gmbh Method for increasing the glutathione level in cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459620B1 (fr) * 1979-06-26 1983-08-05 Agronomique Inst Nat Rech Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
FR2544613B1 (fr) * 1983-04-20 1985-10-25 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique, en reanimation et en therapeutique, renfermant une fraction proteique a base de trois types de minipeptides
EP0357776A4 (en) * 1987-05-14 1991-01-30 Terumo Kabushiki Kaisha Egg white hydrolyzate
CA1338682C (en) * 1988-12-23 1996-10-29 Gustavo Bounous Biologically active undenatured whey protein concentrate as food supplement

Also Published As

Publication number Publication date
CA2060560A1 (en) 1992-08-04
CA2060560C (en) 2002-07-23
EP0502313B1 (en) 1997-07-16
JPH04327537A (ja) 1992-11-17
AU1065992A (en) 1992-08-06
EP0502313A3 (en) 1993-05-12
GR3024638T3 (en) 1997-12-31
EP0502313A2 (en) 1992-09-09
DE69220821T2 (de) 1997-11-20
DE69220821D1 (de) 1997-08-21
ES2106096T3 (es) 1997-11-01
ATE155344T1 (de) 1997-08-15
AU652988B2 (en) 1994-09-15

Similar Documents

Publication Publication Date Title
DK0502313T3 (da) Fremgangsmåde til sikring af tilstrækkeligt intracellulært glutathion i væv
ATE196428T1 (de) Verwendung von gentisinsäure oder gentisylalkohol zur stabilisierung von radio-markierten peptiden und proteinen
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE69429297D1 (de) Zusammensetzung zur Behandlung von Patienten mit Lebererkrankungen
DK524187A (da) Aminosyrechelaterede midler til udlevering til specifikke biologiske vaevssteder
NL300106I2 (nl) N-terminaal chemisch gemodificeerde eiwitpreparaten en werkwijzen.
DE602004012424D1 (de) Homogene herstellungen von il-29
DK1308170T3 (da) Törret blodfaktorpræparat indeholdende trehalose
DE69531314D1 (de) Verwendung von metallionen chelatoren zur stabilisierung von interferon-enthaltenden pharmazeutischen zubereitungen
NO883926D0 (no) Fremgangsmaate for fremstilling av stabilisert humanproteinpreparat.
ATE187335T1 (de) Verwendung von diätetischen molkeproteinen zur behandlung von hiv seropositiven individuen
KR910009246A (ko) 폴리펩타이드를 함유하는 피하투여용 또는 근육내 투여용 약제
DE3686794D1 (de) Reinigung des natuerlichen kolonie-stimulierenden faktors-1.
DE69719931D1 (de) Verwendung von Acetylcystein zur Herstellung eines Arzneimittels zur Behandlung von chronischen Geschwüren
ATE213499T1 (de) Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
HUP9900506A2 (hu) Protrombinszármazékok
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
DK226889D0 (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
DE3769910D1 (de) Verwendung von n, n'-bis-l-aminosaeure-l-cystinpeptiden in aminosaeure-praeparaten fuer orale und parenterale ernaehrung.
EP0515246A3 (fr) Compositions protéiques à textures onctueuse
ATE230587T1 (de) Mittel zur dauerhaften verformung von menschlichen haaren
ATE195322T1 (de) Verwendung von oberflächenaktiven substanzen zur stabilisierung von peptiden und proteinen zur radiopharmazeutischen verwendung
ATE96035T1 (de) Verwendung eines polypeptides mit gammainterferon-aktivitaet zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von primitivem pleura-krebs.
IT1283134B1 (it) Derivati sintetici e semisintetici di somatostatine utili nella stimolazione della crescita corporea, in particolare in
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.